Skip to main content

CVE detail

CVE-2025-20189

A vulnerability in the Cisco Express Forwarding functionality of Cisco IOS XE Software for Cisco ASR 903 Aggregation Services Routers with Route Switch Processor 3 (RSP3C) could allow an unauthenticated, adjacent attacker to trigger a denial of service (DoS) condition. This vulnerability is due to improper memory management when Cisco IOS XE Software is processing Address Resolution Protocol (ARP) messages. An attacker could exploit this vulnerability by sending crafted ARP messages at a high rate over a period of time to an affected device. A successful exploit could allow the attacker to exhaust system resources, which eventually triggers a reload of the active route switch processor (RSP). If a redundant RSP is not present, the router reloads.

CVSS 7.4 · HighBuzz score 11.9

Buzz score

Why this CVE is surfacing

Buzz score total 11.9

This all-time snapshot uses the same composite formula as Trending across a 30-year evidence window, rather than a current rolling window.

Buzz score components · mention 6.9 · diversity 5.0 · KEV 0.0 · OTX 0.0 · PoC 0.0
Mention score
6.9
1 evidence mentions in the snapshot
Diversity score
5.0
1 sources across 1 categories
KEV score
0.0
No KEV entry observed
OTX score
0.0
0 OTX pulses
PoC score
0.0
0 repos · best confidence N/A
Best PoC traction
0
Maximum stars on a matched PoC repo

Why it matters now

Mention timeline

Total mentions
0
within the 30d window
Peak daily
0
highest bucket

Evidence

Source links by recency

Newest mentions first
1 source links · newest first

Exploit code

Public exploit repository references

Public PoC repositories are third-party, potentially unsafe artifacts. Treat their code as untrusted and use it only on authorized systems in an isolated, least-privilege environment. cvebuzz does not execute the code or verify that an exploit works.

0 repository references · best confidence N/A · max 0 stars
No public PoC repositories have been matched yet.

Related records

Similar CVEs

6 related CVEs with shared weakness or product evidence